Radio-Sensitising Effect of T-Dm1 Should Not Be Discarded for the Efficacy of Radiosurgery in the Management of Brain Metastases in Patients With HER2-positive Metastatic Breast Cancer

Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-017-2405-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Risk Factors for the Development of Brain Metastases in Patients With HER2-positive Breast Cancer

ESMO Open
Cancer ResearchOncology
2018English

P3-013a Phase 1b Study of S-1 Combined With Trastuzumab Emtansine (T-Dm1) for HER2 Positive Metastatic Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

T-Dm1 Reduces HER2+ Breast Cancer Recurrence

Cancer Discovery
Oncology
2018English

Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival

British Journal of Cancer
Cancer ResearchOncology
2012English

Management of Brain Metastases in Patients With SCLC: Defining the Role for Stereotactic Radiosurgery

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Stereotactic Radiosurgery in the Management of Brain Metastases

JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA
2018English

Brain Metastases in Patients With Metastatic Breast Cancer : Prognosis According to Subtype

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2017English

T-Dm1 Aids Patients With Advanced Breast Cancer

Cancer Discovery
Oncology
2013English

Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry

Cancers
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy